Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Interest Expenses: 2012-2023

Historic Interest Expenses for RedHill Biopharma (RDHL) over the last 11 years, with Jun 2023 value amounting to $1.9 million.

  • RedHill Biopharma's Interest Expenses fell 54.30% to $1.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was $36.6 million, marking a year-over-year increase of 131.50%. This contributed to the annual value of $2.1 million for FY2024, which is 78.59% down from last year.
  • RedHill Biopharma's Interest Expenses amounted to $1.9 million in Q2 2023, which was up 357.48% from $421,000 recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Interest Expenses registered a high of $31.8 million during Q3 2022, and its lowest value of $74,000 during Q2 2019.
  • Moreover, its 3-year median value for Interest Expenses was $4.0 million (2021), whereas its average is $6.1 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first crashed by 95.69% in 2019, then soared by 4,839.19% in 2020.
  • RedHill Biopharma's Interest Expenses (Quarterly) stood at $187,000 in 2019, then skyrocketed by 2,335.29% to $4.6 million in 2020, then declined by 19.06% to $3.7 million in 2021, then slumped by 32.69% to $2.5 million in 2022, then plummeted by 54.30% to $1.9 million in 2023.
  • Its last three reported values are $1.9 million in Q2 2023, $421,000 for Q1 2023, and $2.5 million during Q4 2022.